Blood Flow Restriction Therapy for Achilles Tendon Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to aid recovery from Achilles tendon injuries using blood flow restriction (BFR) therapy. BFR uses a special cuff to limit blood flow during light exercises, which can enhance strength. Participants will join one of two groups: one receiving standard physical therapy and the other undergoing BFR therapy. This trial suits individuals diagnosed with an Achilles injury who plan to undergo physical therapy.
As an unphased trial, this study provides a unique opportunity to explore innovative recovery methods.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that blood flow restriction therapy is safe for Achilles tendon injury rehabilitation?
Research has shown that blood flow restriction (BFR) therapy is safe and aids individuals with orthopedic issues, such as those recovering from surgery, in gaining strength. Studies have found BFR therapy effective in promoting tendon healing.
For instance, one study discovered that BFR therapy improved tendon function more than a similar therapy without blood flow restriction. Another study found that BFR therapy increased tendon thickness and stiffness, indicators of healing. This therapy involves placing a cuff on the limb and adjusting the pressure, and participants in these studies tolerated it well.
Overall, no major safety concerns have been reported, and BFR therapy is considered a safe and effective method for strengthening muscles and tendons.12345Why are researchers excited about this trial?
Blood flow restriction (BFR) therapy is unique because it uses a special cuff to restrict blood flow to the injured Achilles tendon, creating a low-oxygen environment that can stimulate muscle growth and strength. Unlike the standard physical therapy that primarily focuses on exercises to gradually build strength, BFR offers a novel approach by enhancing muscle adaptation and recovery even with lower intensity exercises. Researchers are excited about BFR because it could potentially speed up recovery times and improve outcomes for tendon injuries, providing an innovative alternative to traditional rehabilitation methods.
What evidence suggests that blood flow restriction therapy is effective for Achilles injuries?
Research has shown that blood flow restriction (BFR) therapy, one of the treatments studied in this trial, can improve tendon health and function. Studies have found that BFR therapy strengthens the Achilles tendon similarly to lifting heavy weights, but without the need for heavy weights. Some reports also indicate that BFR therapy reduces pain and enhances movement for individuals with tendon issues. Even with short-term use, patients have experienced improved strength and blood flow in their tendons. This trial will compare BFR therapy to standard care physical therapy, another treatment arm in the study. Overall, BFR therapy appears to be a promising method for recovering from Achilles injuries.12467
Who Is on the Research Team?
Guillem Gonzalez-Lomas, MD
Principal Investigator
New York Langone Health
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with an Achilles tendon injury who plan to undergo standard physical therapy. It's not suitable for those under 18 or over 65, individuals with mental impairments, patients not opting for the study therapy, vulnerable subjects, or anyone with poor blood circulation or severe high blood pressure.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo blood flow restriction therapy or standard physical therapy for Achilles injury rehabilitation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Blood flow restriction
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor